Molecules in the same family, Glypican-3 and Glypican-5, have been described in melanoma, neuroblastoma, and rhabdomyosarcoma (Saikali and Sinnett, 2000; Nakatsura et al., 2004a,b; Williamson et al., 2007). Here, GPC5 is linked to neuroblastoma.